TASE:ILXHealthcare
Ilex Medical (TASE:ILX) Margins Fall to 5.4%, Sustained Profit Decline Tests Recovery Narratives
Ilex Medical (TASE:ILX) just released its Q3 2025 results, reporting revenue of 219.3 million ILS and basic EPS of 1.51 ILS. The company has seen revenue fluctuate over recent quarters, from 221.7 million ILS in Q3 2023 up to 240.1 million ILS in Q3 2024, before coming in at the latest figure. While EPS has also shown variation from 0.79 ILS in Q3 2023 to 1.16 ILS in Q3 2024, margins remain an area to watch as profitability dynamics continue to shift.
See our full analysis for Ilex...